gvtcx

Support of existing NHSBT owned Extracorporeal Photopheresis (ECP) Systems

NHS Blood and Transplant Published 19 Dec 2024 Find a Tender

key details

Statuscomplete
Category (CPV) 33140000 +2 more
Procedureopen
OCIDocds-h6vhtk-04c960

Award

SupplierValueDateStatus
Therakos (UK), Ltd · · active

description

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system’s utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box. The contract award is for maintenance, training and consumables to support existing Therakos CellEx Extracorporeal Photopheresis machine platforms.<br/>This Contract is for a period of 2 years with one 12-month option to extend.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
28 Jun 2024 Contract notice (F02) Earlier regulations 019765-2024
19 Dec 2024 Contract award notice (F03) Earlier regulations 040875-2024

more from NHS Blood and Transplant

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.